Skip Header

1 - 25 of 31 results for author:"Kanamori M." in Literature citations

Page of 2 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (5,360)

Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.

Suzuki K., Matsui Y., Higashimoto M., Kawaguchi Y., Seki S., Motomura H., Hori T., Yahara Y., Kanamori M., Kimura T.

PLoS ONE 7:e36682-e36682(2012) · Mapped (12)

O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma.

Sonoda Y., Yokosawa M., Saito R., Kanamori M., Yamashita Y., Kumabe T., Watanabe M., Tominaga T.

Int. J. Clin. Oncol. 15:352-358(2010) · Mapped (3)

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients.

Sonoda Y., Kumabe T., Nakamura T., Saito R., Kanamori M., Yamashita Y., Suzuki H., Tominaga T.

Cancer Sci. 100:1996-1998(2009) · Mapped (13)

Long-term survivors of glioblastoma: clinical features and molecular analysis.

Sonoda Y., Kumabe T., Watanabe M., Nakazato Y., Inoue T., Kanamori M., Tominaga T.

Acta Neurochir (Wien) 151:1349-1358(2009) · Mapped (32)

Physical and functional interaction between WRNIP1 and RAD18.

Yoshimura A., Seki M., Kanamori M., Tateishi S., Tsurimoto T., Tada S., Enomoto T.

Genes Genet. Syst. 84:171-178(2009) · Mapped (4)

KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.

Sekiguchi J., Morita K., Kitao T., Watanabe N., Okazaki M., Miyoshi-Akiyama T., Kanamori M., Kirikae T.

Antimicrob. Agents Chemother. 52:4194-4197(2008) · UniProtKB (2)

PDGF receptor beta is a potent regulator of mesenchymal stromal cell function.

Tokunaga A., Oya T., Ishii Y., Motomura H., Nakamura C., Ishizawa S., Fujimori T., Nabeshima Y., Umezawa A., Kanamori M. et al.

J. Bone Miner. Res. 23:1519-1528(2008) · Mapped (7)

Identification and functional analysis of CBLB mutations in type 1 diabetes.

Yokoi N., Fujiwara Y., Wang H.Y., Kitao M., Hayashi C., Someya T., Kanamori M., Oiso Y., Tajima N., Yamada Y. et al.

Biochem. Biophys. Res. Commun. 368:37-42(2008) · Mapped (13)

Novel mating type-dependent transcripts at the mating type locus in Magnaporthe oryzae.

Kanamori M., Kato H., Yasuda N., Koizumi S., Peever T.L., Kamakura T., Teraoka T., Arie T.

Gene 403:6-17(2007) · UniProtKB (12)

Intracranial microenvironment reveals independent opposing functions of host alphaVbeta3 expression on glioma growth and angiogenesis.

Kanamori M., Kawaguchi T., Berger M.S., Pieper R.O.

J. Biol. Chem. 281:37256-37264(2006) · Mapped (7)

BLM is an early responder to DNA double-strand breaks.

Karmakar P., Seki M., Kanamori M., Hashiguchi K., Ohtsuki M., Murata E., Inoue E., Tada S., Lan L., Yasui A. et al.

Biochem. Biophys. Res. Commun. 348:62-69(2006) · Mapped (6)

Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects.

Yokoi N., Kanamori M., Horikawa Y., Takeda J., Sanke T., Furuta H., Nanjo K., Mori H., Kasuga M., Hara K. et al.

Diabetes 55:2379-2386(2006) · Mapped (52)

Downregulation of EphA7 by hypermethylation in colorectal cancer.

Wang J., Kataoka H., Suzuki M., Sato N., Nakamura R., Tao H., Maruyama K., Isogaki J., Kanaoka S., Ihara M. et al.

Oncogene 24:5637-5647(2005) · Mapped (1)

Expression of developmentally regulated endothelial cell locus 1 was induced by tumor-derived factors including VEGF.

Aoki M., Kanamori M., Ohmori K., Takaishi M., Huh N.H., Nogami S., Kimura T.

Biochem. Biophys. Res. Commun. 333:990-995(2005) · Mapped (9)

EPHA2/EFNA1 expression in human gastric cancer.

Nakamura R., Kataoka H., Sato N., Kanamori M., Ihara M., Igarashi H., Ravshanov S., Wang Y.J., Li Z.Y., Shimamura T. et al.

Cancer Sci. 96:42-47(2005) · Mapped (8)

Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells.

Kanamori M., Watanabe S., Honma R., Kuroda M., Imai S., Takada K., Yamamoto N., Nishiyama Y., Kawaguchi Y.

J. Virol. 78:3984-3993(2004) · Mapped (1)

Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer.

Kataoka H., Igarashi H., Kanamori M., Ihara M., Wang J.D., Wang Y.J., Li Z.Y., Shimamura T., Kobayashi T., Maruyama K. et al.

Cancer Sci. 95:136-141(2004) · Mapped (5)

The PDZ protein tax-interacting protein-1 inhibits beta-catenin transcriptional activity and growth of colorectal cancer cells.

Kanamori M., Sandy P., Marzinotto S., Benetti R., Kai C., Hayashizaki Y., Schneider C., Suzuki H.

J. Biol. Chem. 278:38758-38764(2003) · UniProtKB (2) · Mapped (43)

NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6.

Kanamori M., Kai C., Hayashizaki Y., Suzuki H.

FEBS Lett. 532:241-246(2002) · UniProtKB (2) · Mapped (7)

The association of lumbar disc disease with vitamin-D receptor gene polymorphism.

Kawaguchi Y., Kanamori M., Ishihara H., Ohmori K., Matsui H., Kimura T.

J Bone Joint Surg Am 84-A:2022-2028(2002) · Mapped (64)

Negative regulation of EphA2 receptor by Cbl.

Wang Y., Ota S., Kataoka H., Kanamori M., Li Z., Band H., Tanaka M., Sugimura H.

Biochem. Biophys. Res. Commun. 296:214-220(2002) · Mapped (5)

Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer.

Kataoka H., Tanaka M., Kanamori M., Yoshii S., Ihara M., Wang Y.J., Song J.P., Li Z.Y., Arai H., Otsuki Y. et al.

J. Cancer Res. Clin. Oncol. 128:343-348(2002) · Mapped (9)

T2BP, a novel TRAF2 binding protein, can activate NF-kappaB and AP-1 without TNF stimulation.

Kanamori M., Suzuki H., Saito R., Muramatsu M., Hayashizaki Y.

Biochem. Biophys. Res. Commun. 290:1108-1113(2002) · UniProtKB (1) · Mapped (3)

Whole genome sequencing of meticillin-resistant Staphylococcus aureus.

Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., Cui L., Oguchi A., Aoki K., Nagai Y. et al.

Lancet 357:1225-1240(2001) · UniProtKB (5,294)

Multivariate analysis of genetic and acquired factors; T235 variant of the angiotensinogen gene is a potent independent risk factor for preeclampsia.

Kobashi G., Shido K., Hata A., Yamada H., Kato E.H., Kanamori M., Fujimoto S., Kondo K.

Semin. Thromb. Hemost. 27:143-147(2001) · Mapped (9)

to top of page·

Page of 2 | Next »